|
| 6-(1H-indol-4-yl)-4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazole Basic information |
| 6-(1H-indol-4-yl)-4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazole Chemical Properties |
Boiling point | 706.2±70.0 °C(Predicted) | density | 1.281±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO: 33.33 mg/mL (75.66 mM) | form | Solid | pka | 12.90±0.40(Predicted) | color | White to yellow |
| 6-(1H-indol-4-yl)-4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazole Usage And Synthesis |
Biological Activity | Nemiralisib, also known as GSK-2269557, is a potent and selective PI3Kδ inhibitor (pKi=9.9). | in vivo | Nemiralisib has relatively low oral bioavailability (F=2%), in vivo clearance is 28 mL/min/kg, but high volume distribution, 6.3 L/kg. 0.3-1 μMGSK-2269557 induction concentration Dependent QT interval and Tpe prolongation, 1 μM GSK-2269557 resulted in prolongation of the ORS wave, during which no torsades de pointes arrhythmia was observed. | target | Target | Value | PI3Kδ (Cell-free assay) | 9.9(pKi) |
|
| 6-(1H-indol-4-yl)-4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazole Preparation Products And Raw materials |
|